DTIL
Precision BioSciences Inc
$7.86
0.00 (0.00%) Today
— up— down
Market Cap
$203M+87.1%
Revenue (TTM)
$47.21M-11.9%
Net Income (TTM)
$-94,611,180
$-94,611,180EPS (TTM)
-3.67
-3.67Shares Out
25.80M
25.80MOpen
$7.86
$7.86Previous Close
$7.86
$7.86Day Range
$7.82 – $8.32
$7.82 – $8.3252-Week Range
$3.53 – $8.82
$3.53 – $8.82Beta
1.32
1.32Volume
478.64K
478.64KAvg Volume
338.06K
338.06KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout DTIL
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.